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Charlotte, North CarolinaABSTRACT Conserved active-site elements in myosins and other P-loop NTPases play critical roles in nucleotide binding and
hydrolysis; however, the mechanisms of allosteric communication among these mechanoenzymes remain unresolved. In this
work we introduced the E442A mutation, which abrogates a salt-bridge between switch I and switch II, and the G440A mutation,
which abolishes a main-chain hydrogen bond associated with the interaction of switch II with the g phosphate of ATP, into
myosin V. We used fluorescence resonance energy transfer between mant-labeled nucleotides or IAEDANS-labeled actin
and FlAsH-labeled myosin V to examine the conformation of the nucleotide- and actin-binding regions, respectively. We demon-
strate that in the absence of actin, both the G440A and E442A mutants bind ATP with similar affinity and result in only minor
alterations in the conformation of the nucleotide-binding pocket (NBP). In the presence of ADP and actin, both switch II mutants
disrupt the formation of a closed NBP actomyosin.ADP state. The G440A mutant also prevents ATP-induced opening of the
actin-binding cleft. Our results indicate that the switch II region is critical for stabilizing the closed NBP conformation in the
presence of actin, and is essential for communication between the active site and actin-binding region.INTRODUCTIONMyosins are a superfamily of actin-based molecular motors
that use the free energy released from ATP hydrolysis to
perform mechanical work. To understand the mechanism
of force generation in myosins, we must first elucidate the
allosteric communication pathways that are critical for
motor function. The well-established lever arm hypothesis
suggests that communication between the nucleotide-
binding region and the light-chain-binding region or lever
arm is critical for force generation (1). In addition, cyclic
attachment and detachment from actin is thought to be
accomplished by nucleotide-dependent conformational
changes in the actin-binding cleft, which has been shown
to be more open in the weak actin-binding states and more
closed in the strong actin-binding states (2–4). However,
the details of how the active site coordinates communication
with the lever arm and actin-binding region are currently
unclear.
The overall architecture of most myosins consists of
a well conserved structural core surrounding the nucleo-
tide-binding pocket (NBP), with minor modifications that
lead to different mechanochemical properties required
for tuning each myosin for a specific biological function
(5,6). Interestingly, myosins share sequence and structural
homology with G-proteins and other NTPases (7), and use
a similar mechanism of nucleotide binding and hydrolysis.
The three well-conserved regions in the P-loop family
of NTPases (8) involved in performing this task are the
P-loop, switch I, and switch II. The mechanism of com-Submitted November 13, 2011, and accepted for publication April 17, 2012.
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0006-3495/12/06/2545/11 $2.00municating conformational changes from the active site to
the protein effector binding site or track may be conserved
in these structurally related NTPases (9,10). Studies have
demonstrated that the reversible movement of switch I
is coupled to the coordinated opening of the actin-binding
cleft and closing of the NBP (9,11). Conformational
changes in switch II are directly coupled to the kink in the
relay helix, which allows for positioning of the lever arm
and formation of the prepower stroke state (12,13). Hence,
it is thought that switch I is chiefly involved in the com-
munication pathways between the active site and the
actin-binding cleft (14), and switch II mediates the com-
munication to the converter-lever arm domain (12). Muta-
genesis studies have provided support for this hypothesis
(15–17). However, several studies have demonstrated that
force generation in myosins is intimately associated with
the transition from weak to strong actin binding (2,3).
Thus, we hypothesize that the switch II region may be crit-
ical for providing allosteric coupling between the actin-
binding, active-site, and lever-arm domains. Because the
role of switch II in mediating the lever-arm position has
been well established, it is critical to examine the role of
switch II in mediating allosteric communication between
the active site and actin-binding region.
A fundamental feature of myosins and other molecular
motors is that external load can alter catalytic activity,
which allows these mechanoenzymes to function in diverse
physiological environments. It has been proposed that load
or strain placed on the lever arm alters the conformation
of the NBP and either enhances or decreases the rate of
ADP release depending on the direction of strain (18–21).
This mechanism implies that coupling occurs between thedoi: 10.1016/j.bpj.2012.04.025
2546 Trivedi et al.lever arm and NBP in the ADP release steps, while the
structural mechanism of this coupling is unknown. We
found in our previous work that myosin V labeled with
FlAsH (MV FlAsH) in the upper 50-kDa domain can
serve as a fluorescence resonance energy transfer (FRET)
acceptor for mant-labeled nucleotides (dmantADP/ATP)
as well as IAEDANS-labeled actin (IAEDANS-actin) (22).
Our studies demonstrated that the dmantADP/ATP-MV
FlAsH pair is sensitive to the motion of the upper 50-kDa
domain relative to the NBP, and therefore we attributed
the FRET changes observed to a general opening/closing
of the NBP (22,23). Specifically, we found a more closed
conformation in the presence of ATP compared with ADP
at 25C. Furthermore, in the presence of ADP, a more closed
state was prominent at low temperatures (4–15C) com-
pared with higher temperatures (25–35C). Kinetic studies
showed that ADP release occurs in two conformational steps
in MV: a transition from a more closed to a more open NBP,
followed by the release of ADP from the open state (24,25).
We hypothesize that the switch II region is involved in this
temperature-dependent conformational change in the NBP
providing a mechanism of coupling the NBP and lever
arm and mediating strain-dependent ADP release.
In this work we introduced two single site mutations at
conserved residues into the switch II region of MV. We
investigated the G440A mutant, which abolishes a highly
conserved hydrogen bond to the g phosphate of ATP, and
the E442A mutant, which abrogates a highly conserved
salt bridge between switch I and switch II (16,26). Both of
these mutants inhibit the hydrolysis of ATP, as shown in
studies of MV (26), Dictylostelium (residues G457A and
E459A) (16,27), and smooth muscle myosin II (residues
G468A and E470A) (28–30). We used our established
FRET probes (22,23,31) and a combination of equilibrium
and transient kinetic measurements to examine the impact
of the switch II mutations on key conformational changes
in the nucleotide- and actin-binding regions. Our results
establish a role for switch II in mediating the conformation
of the NBP, which is important for the structural mechanism
of ADP release from actomyosin. In addition, we establish
a critical role for switch II in communicating conforma-
tional changes between the active site and actin-binding
regions.MATERIALS AND METHODS
Reagents
Commercially available reagents of highest purity were used for all experi-
ments. ATP and ADP were freshly prepared from powder, and dmantADP
and dmantATP (N-methylanthraniloyl (mant)-labeled 20deoxy ADP or
20deoxy ATP) were purchased from Jena Bioscience (Jena, Germany). The
ATP and ADP concentrations were measured by absorbance at 259 nm
(ε259 ¼ 15,400 M1cm1). The dmantADP/ATP concentrations were deter-
mined by absorbance measurements at 255 nm (ε255 ¼ 23,300 M1cm1).
The IAEDANS(5-(((2-iodoacetyl)amino)ethyl)amino)-naphtalene-1-sulfonic
acid) fluorophore was purchased from Invitrogen (Carlsbad, CA), and FlAsHBiophysical Journal 102(11) 2545–2555was generously provided by Roger Tsien and Stephen Adams (University of
California, San Diego).MV c-DNA construction, expression, and
purification
We used a chicken MV construct containing a single IQ motif (residues
1–792), a tetra-cysteine motif in the upper 50-kDa domain for FlAsH
labeling (22,23,31), and a C-terminal FLAG tag for purification. The two
switch II mutations, E442A and G440A, were separately introduced into
MV containing the tetra-cysteine. All constructs were coexpressed with
chicken calmodulin in the baculovirus system (22,23,31). We labeled
MVE442A, MVG440A, and MV (wild-type) with FlAsH as described previ-
ously (23,31). Actin was purified from rabbit skeletal muscle according
to the acetone powder method (32). F-actin was labeled with IAEDANS
as described previously (22,31). All experiments were performed in
KMg50 TCEP buffer (50 mM KCl, 1 mM EGTA, 1 mM MgCl2, 1 mM
TCEP, 10 mM imidazole-HCl at pH 7.0, 25C).Fluorescence spectroscopy
The steady-state fluorescence of dmantATP/ADP, MV FlAsH, and
IAEDANS actin was measured on a Quantamaster fluorometer (Photon
Technology International, Lawrenceville, NJ) equipped with a 75-W xenon
arc lamp as an excitation source and excitation/emission monochromators.
The donors (dmantATP/ADP and IAEDANS actin) were excited at 365 nm
and the emission spectra were measured from 400 nm to 600 nm. All
spectra were corrected for the Raman scatter and background fluorescence
in the appropriate buffer solution.
Fluorescence lifetime experiments were performed with a TimeMaster
fluorescence spectrometer (Photon Technology International) equipped
with a picosecond pulse N2 dye laser. The donor (IAEDANS-actin) was
excited at 366 nm with the N2 dye laser and the emission was measured
through a single grating monochromator set at 470 nm. The time required
to acquire the lifetime decay was% 3 min, which previous results suggest
would result in a small amount of ATP hydrolysis at 25C (%1% of 1 mM
ATP) in MVG440A mutant (26). Fluorescence decays were analyzed with
software provided with the instrument.FRET measurements
We measured the distances between the donor fluorophores (dmantADP/
ATP or IAEDANS-actin) and the acceptor fluorophore (FlAsH-labeled
MV) by FRET using the Forster energy transfer theory (22,23,31,33). We
examined the steady-state FRET efficiency (E) by examining enhancement
in the acceptor (MV FlAsH) fluorescence in the presence of varied donor
(dmantATP/ADP or IAEDANs-actin) concentrations (22). Distances
between the donor and acceptor fluorophores were calculated as described
previously (22). The quantum yields of dmantADP/ATP bound to acto-MV
and MV at all temperatures (4–35C) and IAEDANS-actin/MV at 25C
determined previously (22,23) were included in the distance calculations. In
the IAEDANS-actin and MV FlAsH experiments, we measured the time-
resolved FRET efficiency by determining the donor lifetime (IAEDANS-
actin) in the presence of the labeled (IAEDANS-actin/MV FlAsH) or
unlabeled (IAEDANS-actin/MV) acceptor (31).Stopped-flow measurements
All transient kinetic experiments were performed in a stopped-flow appa-
ratus (Applied Photophysics, Surrey, UK) with a dead time of 1.2 ms. A
monochromator with a 2-nm band pass was used for excitation, and cutoff
filters provided with the instrument were used to measure the fluorescence
emission. The dmantATP/ADP or IAEDANS-actin fluorescence was ex-
cited at 365 nm in the presence of MV FlAsH, and the FRET emission
Switch II Couples Nucleotide- and Actin-Binding Regions 2547was measured with a 515-nm long-pass filter. The data were fit by nonlinear
least-squares fitting using software provided with the instrument or
Kaleidograph (Synergy Software, Reading, PA). Uncertainties reported
are the standard error of the fits.
We analyzed the kinetic data using the kinetic scheme established
from previous MV studies (22,24,25,34). The point mutations, G440A and
E442A, were both previously determined to dramatically reduce ATP hydro-
lysis and trapMVin prehydrolysis ATP states (26). Kinetic modeling was per-
formed with analysis software provided with the stopped-flow instrument.Geometrical simulation (FIRST/FRODA)
We generated all-atom trajectories using the Floppy Inclusion and Rigid
Substructure Topology (FIRST)/Framework Rigidity Optimized Dynamic
Algorithm (FRODA) software (35), version 6.2. The geometrical simula-
tion paradigm (36,37) represents the molecular structure as a distance
constraint network (36–38), which is used to explore accessible motions
at the all-atom level of resolution. The FRODA simulations performed in
this work mirror those of our previous study (22), with the exception of
the starting structures. See the Supporting Material for additional informa-
tion on geometric simulations.SCHEME 2RESULTS
In this work we used temperature-dependent FRET to
examine the impact of the switch II mutations on the equi-
librium between conformational states and the structural
dynamics of specific structural states. Schemes 1 and 2 sum-
marize key studies in the literature and describe the current
results.
Investigators have examined the relative movements of
switch I and switch II in solution studies using single tryp-
tophan probes in Dictyostelium and smooth muscle myosin
II (39–42), in complement to high-resolution structural
studies (3). In the absence of actin, tryptophan fluorescence
studies (9,43) have shown that switch I moves rapidly from
an open to a closed conformation upon binding ATP (K2),
followed by the movement of switch II into a closed hydro-
lysis-competent state (K3A). The conserved tryptophan on
the rigid relay loop, which is sensitive to the conformation
of switch II, shifts from a quenched (My.ATP) to a high
(M*.ATP) fluorescence state during this transition.Scheme 1SCHEME 1Spectroscopic studies demonstrate that switch I is in equi-
librium between the open and closed conformation uponADP binding (9,22,44), which corresponds to the previ-
ously proposed weak (AM.ADPW) and strong (AM.ADPS)
ADP affinity states (24,25), respectively. Our previous
results obtained with the mant-FlAsH pair suggest that
the closed conformation is more favored at low tempera-
ture (22). Furthermore, results for the IAEDANS-FlAsH
pair show that the actin-binding cleft remains closed in
both conformations, suggesting that switch I adopts a novel
conformation in the AM.ADPS state. Tryptophan fluores-
cence studies suggest that switch II is sensitive to ADP
(41) binding, while it is unclear whether it is capable of
adopting a closed switch II conformation in the AM.ADPS
state.Scheme 2Conformational changes in the NBP
We first examined the role switch II in mediating the ATP-
binding-induced closure of the NBP in the absence of actin
(Scheme 1). The FRET efficiencies were measured by
acceptor enhancement (22,23,31) as a function of donor
concentration at 4C and 35C, and were fit to a quadratic
(dmantATP) or hyperbolic (dmantADP) function to measure
the efficiency at 100% bound nucleotide (22,23). In the
absence of actin, we examined 0.5mM MVE442A FlAsH
(Fig. 1 A) or 0.5 mMMVG440A FlAsH (Fig. 1 B) in the pres-
ence of the indicated concentrations of dmantATP at 4C
and 35C. Based on the quadratic fits, the apparent affinities
(KApp) of MV
G440A and MVE442A FlAsH for dmantATP
were similar at both 4C (KApp ¼ 0.02 5 0.01 mM) and
35C (KApp ¼ 0.07 5 0.01 mM). The FRET efficiency
between dmantATP and MVE442A FlAsH was quite high
and similar at both 4C and 35C. The results for
MVE442A FlAsH are similar to our results for wild-type MV
FlAsH, in that a stable (temperature-independent) closed
NBP conformation is observed in the presence of ATP (22).
The FRET efficiency between dmantATP and MVG440A
FlAsH also indicated a closed pocket conformation at
4C, but there was a slight reduction in FRET efficiency at
35C. The change in FRET observed in the G440A mutant
at 35C was relatively small but clearly different from that
seen in the E442A mutant, suggesting that the closed NBPBiophysical Journal 102(11) 2545–2555
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FIGURE 2 Conformation of the NBP of acto-MVE442A and MVE442A
FlAsH as a function of temperature in the presence of dmantADP. The
steady-state FRET of MVE442A FlAsH (A) or acto-MVE442A FlAsH (B)
was measured with increasing concentrations of dmantADP at 4C and
35C and fit to a hyperbolic function to determine efficiency at 100% bound
nucleotide. Error bars represent the SD from at least three separate exper-
iments done with at least three different protein preparations.
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FIGURE 1 Conformation of the NBP of MV FlAsH as a function of
temperature in the presence of dmantATP. Steady-state FRET was moni-
tored by acceptor enhancement in MVE442A FlAsH (A) or MVG440A FlAsH
(B) in the presence of increasing concentrations of dmantATP at 4C and
35C. The FRET efficiency as a function of dmantATP concentration was
fit to a quadratic function to determine the efficiency at 100% bound nucle-
otide. Error bars represent the SD from at least three separate experiments
done with at least three different protein preparations.
2548 Trivedi et al.conformation is less stable as a result of the G440A
mutation.
To determine whether the G440A mutation alters the
dmantATP dissociation pathway (k-1 or k-2), we mixed a
complex MVG440A FlAsH/dmantATP with saturating ATP
in the stopped-flow apparatus. The resulting fluorescence
transients were fit to a biexponential function (0.02 5
0.001 and 0.04 5 0.003 s1 with relative amplitudes of
85% and 15%, respectively; see Fig. S1) and found to be
similar to the steady-state ATPase rate (26). These results
suggest that the G440A mutation does not significantly alter
the dissociative pathway, and that it likely inhibits hydro-
lysis by dramatically slowing the formation (K3A) of the
hydrolysis competent state (M*.ATP).
We examined the impact of switch II mutants on the
formation of the closed NBP conformation in the pre-
sence of ADP, characterized in our previous work (22,23)
(Scheme 2). We measured 0.5 mM MVE442A FlAsH
(Fig. 2 A) or acto-MVE442A FlAsH (Fig. 2 B) in the presence
of dmantADP at 4C and 35C. Only MVE442A FlAsH was
examined in the presence of dmantADP in steady-state
experiments because MVG440A has a reduced affinity for
ADP (26). The FRET efficiency of MVE442A FlAsH in the
presence of dmantADP was found to be similar to our re-
ported results with wild-type MV FlAsH in that the distance
between the mant-FlasH pair was highly temperature depen-
dent (22), as demonstrated by a 2 A˚ increase in distance at
35C compared with 4C. However, in the presence of actin,
FRET between dmantADP and MVE442A FlAsH was low at
both 4C and 35C, and similar to the FRETefficiency in the
absence of actin at 35C. Thus, the E442A mutation inhibits
the transition (K5A) into the closed NBP AM.ADPS state,
which is more populated at low temperature. The efficien-
cies of energy transfer measured represent the average
from at least three experiments done with three different
protein preparations. The FRET efficiencies and calculatedBiophysical Journal 102(11) 2545–2555distances between the donor and acceptor fluorophores are
summarized in Table 1.
Conformational changes in the actin-binding cleft
We investigated the impact of the switch II mutants on ATP-
induced opening of the actin-binding cleft. We measured the
efficiency of energy transfer between 0.5mMMVG440A FlAsH
in the presence of increasing concentrations of IAEDANS-
actin at 25C in the nucleotide-free (rigor) state and in thepres-
ence of 1 mMATP. A previous study demonstrated that 1 mM
ATP is capable of saturating the active site of MVG440A under
these conditions (26). The FRET efficiency and calculated
distance between the FlAsH and IAEDANS probes were
found to be similar in both the rigor and ATP states (Fig. 3 A
and Table 2). We also investigated the time-resolved FRET
by examining the fluorescence lifetime of IAEDANS-actin
in the presence of MVG440A FlAsH or unlabeled MVG440A
in the presence and absence of ATP (Fig. 3 B and Table S1).
The time-resolved FRET results also showed a distance
between the IAEDANS and FlAsH probes similar to that
found in the steady-state FRET. In comparison, we previously
reported that MVE442A FlAsH in the presence of IAEDANS-
actin showed a significantly higher FRET in the rigor state
(closed cleft) than in the presence of ATP (open cleft) (31).
We examined the kinetics of MVG440A FlAsH binding to
IAEDANS-actin in the presence of ATP (Fig. 3 C) and inter-
preted these results in terms of Scheme 1. We rapidly mixed
a complex of MVG440A FlAsH.ATP (1 mM final concentra-
tion of ATP) with 5- to 10-fold excess IAEDANS-actin in
the stopped-flow apparatus, and measured the binding rates
by following acceptor enhancement. We found that the
fluorescence transients contained two phases: a fast phase
that was dependent on the IAEDANS-actin concentration,
and a slow phase that was independent of the IAEDANS-
actin concentration. The relative amplitudes of the fast
(~80%) and slow (~20%) phases were similar at each
IAEDANs-actin concentration measured. The linear actin
TABLE 1 Summary of FRET measurements with dmantATP/dmantADP and MV FlAsH
Nucleotide state FRET efficiency (4C) FRET efficiency (35C) r(A˚) (4C) r(A˚) (35C)
MVG440A FlAsH.dmantATP* 0.855 0.01 0.745 0.01 21.45 0.3 23.35 0.2
MVE442A FlAsH.dmantATP* 0.845 0.01 0.795 0.04 21.65 0.3 22.25 0.9
MVE442A FlAsH.dmantADPy 0.775 0.02 0.625 0.04 23.25 0.4 25.55 0.7
Acto-MVE442A FlAsH.dmantADPy 0.585 0.03 0.605 0.04 26.35 0.5 26.05 0.7
*FRET efficiency/distance determined by steady-state FRET, data in Fig. 1.
yFRET efficiency/distance determined by steady-state FRET, data in Fig. 2.
Switch II Couples Nucleotide- and Actin-Binding Regions 2549dependence of the fast phase allowed us to determine the
second-order binding constant (kon ¼ 2.05 0.1 mM1$s1)
for MVG440A FlAsH.ATP binding to IAEDANs-actin. We
determined the dissociation rate constant by mixing a
complex of MVG440A FlAsH.ATP/IAEDANS-actin with
20-fold excess unlabeled F-actin. The fluorescence tran-
sients (Fig. 3 D) were best fit to a single exponential (koff ¼
0.1 5 0.01 s1) with a linear phase that was similar to the
photobleaching rate. The rates of binding are similar to
the measured rates of MV.ADP binding, but much slower
than the binding of nucleotide-free MV to actin (34). The
calculated dissociation constant (KD ¼ 0.10 5 0.01 mM)
determined from the association and dissociation rate
constants was similar to the previous results obtained with
MVG440A measured by actin cosedimentation (26).30 35 40 45 50
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To further characterize the conformation of MVE442A
FlAsH bound to dmantADP, we examined the kinetics of
dmantADP release in the presence and absence of actin at
a series of temperatures between 4C and 35C. In the
experiments performed in the absence of actin, a complex
of MVE442A FlAsH.dmantADP was rapidly mixed with
saturating ATP (final concentrations: 0.25 mM MVE442A
FlAsH, 5 mM dmantADP, and 1 mM ATP) and the FRET
signal was measured as described previously (22). We
used Scheme 2 to model the dissociation of dmantADP
from MV FlAsH at all temperatures (22,24). In the absence
of actin, we observed biphasic fluorescence transients that
were fit to a two-exponential equation at all temperatures55 60 65 70
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FIGURE 3 Conformation of the actin-binding
cleft measured with MVG440A FlAsH and
IAEDANS-actin. (A) Steady-state FRET was
measured by acceptor enhancement in MVG440A
FlAsH in the presence of increasing concentrations
of IAEDANS-actin in the absence and presence of
1 mMATP. The data were fit to a quadratic function
to determine the FRET efficiency, as in Fig. 1. Error
bars represent the SD from at least three separate
experimentswith three different proteinpreparations.
(B) Time-resolvedFRETmeasured by examining the
fluorescence lifetime decays of IAEDANS-actin
complexed with MVG440A or MVG440A FlAsH in
the presence and absence of 1 mMATP. All lifetime
decays were fit to a two-exponential decay (see
Table S1 for the parameters of each fit). (C) The
kinetics of the changes in FRET observed upon
MVG440A FlAsH binding to IAEDANS-actin in the
presenceof 1mMATPwere examinedbymonitoring
acceptor enhancement in the stopped flow. We ob-
served a fast phase that was linearly dependent on
IAEDANS-actin concentration and a slow phase
thatwas independent of IAEDANS-actin. (D) A fluo-
rescence transient of MVG440A FlAsH.ATP dissocia-
tion from IAEDANS-actin fit to a single exponential
function with a linear phase. Fluorescence transients
from mixing MVG440A FlAsH.ATP with 2 mM
IAEDANS-actin (trace 2) or 4 mM IAEDANS-actin
(trace 1) are shown in the inset.
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TABLE 2 Summary of FRET measurements with IAEDANS
actin and MV FlAsH
Nucleotide state FRET efficiency r(A˚)
MVG440A.FlAsH/IAEDANS-Actin.Rigor* 0.335 0.01 57.45 0.4
MVG440A.FlAsH/IAEDANS-Actin.ATP* 0.285 0.02 59.75 1.0
MVG440A.FlAsH/IAEDANS-Actin.Rigory 0.245 0.02 61.85 1.1
MVG440A.FlAsH/IAEDANS-Actin.ATPy 0.235 0.01 62.45 0.6
*FRETefficiency/distance determined by steady-state FRET, data in Fig. 3A.
yFRET efficiency/distance determined by lifetime-based FRET, data in
Fig. 3 B.
2550 Trivedi et al.(Fig. 4). Both the fast and slow phases were temperature
dependent, with the fast phase being more steeply depen-
dent on temperature (Fig. 4 A). The amplitudes of the fast
and slow phases were also temperature dependent, with
the slow phase being more dominant at lower temperatures
and the fast phase more dominant at higher temperatures
(Fig. 4 B). Identical experiments were performed with
wild-type MV FlAsH in the absence of actin, which also
showed two phases of dmantADP release. The rate
constants for the fast and slow phases were quite similar
in the wild-type MV FlAsH and MVE442A FlAsH, whereas
the relative amplitudes were slightly different. We also
performed dmantADP dissociation experiments in the pres-
ence of actin by mixing a complex of acto-MVE442A
FlAsH.dmantADP with saturating ATP (final concentra-
tions: 0.25 mM MVE442A FlAsH, 5 mM dmantADP, 1 mM0.001 0.01 0.
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Biophysical Journal 102(11) 2545–2555ATP, and 0.5 mM actin). Interestingly, the fluorescence tran-
sients fit well to a single exponential function and were most
similar to the fast phase of MVE442A FlAsH without actin at
temperatures above 25C (Fig. 4, A and C). Our previous
results showed two phases of dmantADP release from
acto-MV FlAsH (22), highlighting the impact of the
E442A mutation on the actoMV.ADP state. A summary of
the values for the fast and slow phase rate constants and
the relative amplitudes of the fast phase as a function of
temperature are shown in Table S2. The kinetic analysis
complements the steady-state FRET results, which in
concert demonstrate that the E442A mutation disrupts the
formation of the AM.ADPS state in which the NBP is
more closed.
We also examined dmantADP release from MVG440A
FlAsH in the presence and absence of actin (Fig. S2 A), as
described above for MVE442A FlAsH. The fluorescence tran-
sients were found to follow a single exponential function
at all temperatures except 4C, where a slow phase (0.2–
0.4 s1) of small relative amplitude (~10% of total) was
observed in the presence and absence of actin (Fig. S2 B).
In some fluorescence transients, we observed a small fluo-
rescence increase (~5% of total) after the initial drop in
fluorescence (Fig. S2 B). The rate of dmantADP dissocia-
tion was found to be 5- to 10-fold faster than wild-type
and MVE442A FlAsH at all temperatures, suggesting that
the G440A mutant alters the rate constant for ADP release1 1 10
(sec)
D
25 30 35 40
ure (°C)
B
FIGURE 4 Kinetics of dmantADP dissociation
from MVE442A FlAsH in the presence and absence
of actin monitored by stopped-flow FRET. A com-
plex of MVor MVE442A FlAsH and dmantADP was
mixed with saturating ATP, and the fluorescence
transients were monitored by acceptor fluorescence
(ex. 365, em. 515 long-pass filter). All traces were
fit to a biexponential function in the absence of
actin. (A) The slow and fast phases of wild-type
MV FlAsH and MVE442A FlAsH are plotted as a
function of temperature. (B) The relative ampli-
tudes of slow and fast phases of MV FlAsH and
MVE442AFlAsH are plotted as a function of
temperature. (C) Kinetics of dmantADP dissocia-
tion from acto-MVE442A FlAsH as a function of
temperature. The fluorescence transients for acto-
MVE442A FlAsH were fit to a single exponential
function at all temperatures, and the published
values for wild-type acto-MV FlAsH (22) are
shown for comparison. (D) Representative fluores-
cence transients of dmantADP dissociation from
MVE442A FlAsH in the presence (line 1) and
absence (line 2) of actin at 25C fit to a single-
or double-exponential function, respectively.
Switch II Couples Nucleotide- and Actin-Binding Regions 2551from the M.ADPW state (k-5B). In addition, our results show
that the G440A mutant blocks the transition into the
M.ADPS state (K5A) in the presence and absence of actin.
Computational modeling of the nucleotide- and actin-binding
regions
Introducing the switch IImutations in silico into theMVATP,
ADP, and rigor structures had only a minor impact on the
overall flexibility, as demonstrated by the three root mean-
square deviation plots in Fig. S3, A–C. We performed a prin-
cipal component analysis (PCA) to examine the correlated
motions of the NBP. This allowed us to determine whether
the mutations disrupt the correlated motions of specific
elements of the active site. A subspace analysis of the NBP
in the ATP state reveals reduced mobility of switch I in the
G440Amutant (Fig. S4 A). Themobility of the P loop, which
is directly connected to the HF helix and loop 1, is increased
by both switch II mutants (Fig. S4 A and Fig. 5). The mutants
have altered conformational flexibility of the N-terminal
region of switch II and especially D437, which has been
implicated to coordinate magnesium through a water mole-
cule (Fig. S4 and Fig. S5). A subspace analysis of the
actin-binding region, chiefly defined by the upper and lower50-kDa subdomains, reveals that the G440A mutation alters
the mobility of specific elements of the actin-binding region
(see Discussion). In the rigor state, the G440A mutant
increases the dynamics of a region of the upper 50-kDa
domain, including the cardiomyopathy loop and C-terminus
of the HO-helix (Fig. S4 B and Fig. S5). There is also
a dramatic increase in the mobility of the helix-loop-helix
region of the lower 50-kDa domain (Fig. S4 B).DISCUSSION
Defining conserved mechanisms of allosteric com-
munication in myosin motors requires a combination of
high-resolution structural studies and solution studies that
characterize the conformational changes associated with
specific biochemical transitions. We have demonstrated
the importance of conserved residues in the switch II region
(G440 and E442) of myosin in coordinating conformational
changes in the NBP and communicating conformational
changes from the active site to the actin-binding region.
Our results show that the switch II region plays a minor
role in the ATP-binding-induced closure of the NBP in the
absence of actin. Interestingly, in the presence of actin,FIGURE 5 Crystal structure of MV in the ADP-
BeFX state (PDB: 1w7j) showing the upper 50-kDa
(U50) and lower 50-kDa (L50) subdomains along
with the actin- and nucleotide-binding regions
(top). Elements involved in coordination of the
nucleotide and communication between the actin-
and nucleotide-binding regions (discussed in text)
are magnified (bottom).
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2552 Trivedi et al.the switch II mutants have a more dramatic impact on
nucleotide-induced conformational changes in the NBP.
We also demonstrate that the switch II region is essential
for communication between the active site and the actin-
binding region, which is required for ATP-induced dissoci-
ation of actomyosin. Finally, we define a role for switch II in
mediating a key conformational change in the NBP associ-
ated with the release of ADP from actomyosin.Switch II plays a minor role in NBP closure
in the absence of actin
The movement of switch I is proposed to correlate strongly
with rotation of the upper 50-kDa region (9,11,14), which
suggests that FRET between dmantATP/ADP and MV
FlAsH is most sensitive to the open-closed conformation
of switch I. The residues of switch I are highly conserved
and intimately involved in coordinating magnesium and
the g-phosphate of ATP. Additionally, R219 of switch I
forms a highly conserved salt bridge with E442 of switch
II that helps to retain a water molecule at the appropriate
position in the active site to initiate hydrolysis (27). The
G440 residue of switch II acts as a pivot that aids in the rota-
tional motion of switch II into the closed state (16,45). Our
results suggest that the salt bridge mutant, E442A, like wild-
type MV (22) adopts a switch I closed conformation in the
presence of ATP at both higher and lower temperatures.
These results suggest that the MV.ATP state forms a highly
stable closed NBP conformation that does not require the
salt bridge for this stability. The E442A mutant at least
partially transitions into the switch II closed conformation
(M*.ATP), as indicated in a previous study that monitored
tryptophan fluorescence (26). Interestingly, the G440A
mutation does not prevent the formation of a closed switch
I conformation at low temperature in the presence of ATP
(Fig. 1 B), and, based on the lack of tryptophan fluorescence
enhancement, prevents transition (K3A) into the switch II
closed conformation (26). Our results indicate that the
G440A mutation destabilizes the closed switch I conforma-
tion, as demonstrated by a slight opening of the NBP at
higher temperatures. Overall, our results show that the
switch II mutations result in only a minor impact on NBP
closure in the absence of actin, and provide further support
for the notion that switch I plays a dominant role in trapping
the nucleotide in the active site of myosin.
Our computational modeling results suggest that the
switch II mutations can impair not only the motion of switch
II but also the dynamics of switch I and the P loop
(Fig. S4 A). The reduced mobility of switch I in G440A
may prevent switch I-switch II interactions and reduce the
stability of the closed NBP conformation, which we ob-
served at higher temperatures in the presence of ATP. In
addition to the salt bridge, interactions between Y429 of
switch II and the backbone carbonyl of L243 and R219 of
switch I have been suggested to be important in the closedBiophysical Journal 102(11) 2545–2555NBP conformation (46). The mobility of the P loop, which
is directly connected to the HF helix and loop 1, is increased
by both switch II mutants. These results suggest that muta-
tions in the switch II region can alter the coordinated
motions of the HF helix/P-loop, switch I, and switch II, all
of which may be involved in forming the highly stable
closed NBP conformation in the presence of ATP.Switch II plays an essential role in communicating
conformational changes from the active site to
the actin-binding region
Our results suggest that both switch I and switch II are
important for coordinating closing of the NBP with opening
of the actin-binding cleft during ATP-induced dissociation
of actomyosin. Previous studies with E442A showed that
the actin-binding cleft is open in the presence of ATP, which
subverts the importance of the salt bridge between switch I
and switch II during ATP-induced dissociation of actomy-
osin (31). On the contrary, the G440A mutant has an ex-
tremely weak affinity for ATP in the presence of actin
(26) and disrupts the formation of an open cleft state upon
binding of ATP (Fig. 3). Our results suggest that the
G440A mutation inhibits the formation of the switch I
closed/actin-binding cleft open conformation in the pres-
ence of actin (K02). Simulation and experimental studies
have demonstrated the role of switch I in opening the
actin-binding cleft upon binding of ATP (9,14). The HO
helix around which most of the upper 50-kDa domain is
organized receives two inputs about the status of the nucle-
otide in the active site. One is through the switch I-HG/HH
helix-HO helix route (47), as described below, and the other
may be through the switch II-HO helix route (Fig. 5). More-
over, the HO helix at its C-terminus ends in a charged loop,
called the cardiomyopathy loop, that directly interacts with
actin and is known to harbor disease-causing mutations (48).
The ATP-binding-induced movement of switch I into
the closed conformation displaces the adjoining HG/HH
helices, pulling the HO helix and eventually breaking
a series of hydrogen bonds associated with actin-binding
cleft opening (4,47). Switch II connects the HO helix to
the relay helix via the fifth b strand of the seven-stranded
transducer region. The status of the nucleotide may be trans-
mitted to the actin-binding region via the switch II-HO helix
pathway, and to the lever arm via the switch II-relay helix
pathway (49). The G440A mutation may disrupt the com-
munication route passing through switch II to the HO helix
and lead to a closed cleft state even in the presence of ATP.
Our computational modeling supports this conclusion,
because in the rigor state the G440A mutation increases
the flexibility of a region of the upper 50-kDa domain,
including the cardiomyopathy loop and C-terminus of the
HO helix (Fig. 5, Fig. S4, and Fig. S5). The switch II region
may also communicate conformational changes to the lower
50-kDa domain of the actin-binding region. Computational
Switch II Couples Nucleotide- and Actin-Binding Regions 2553modeling suggests that the G440A mutation causes a
dramatic increase in the mobility of the helix-loop-helix
region of the lower 50-kDa domain (Fig. S4 B). Previous
work suggested that F441 may be a key residue that couples
switch II and the lower 50-kDa subdomain of the actin-
binding region (16). Our simulation results show that F441
is highly dynamic in G440A in the ATP and nucleotide-free
states (Fig. 5, Fig. S4, and Fig. S5), which may prevent its
interaction with the surrounding hydrophobic cluster of
the lower 50-kDa subdomain. Thus, conformational changes
in switch II may be a triggering event (50) that leads to
opening of the actin-binding cleft and dissociation of the
actomyosin complex. Our results suggest that the described
communication pathways between the active site and the
upper and lower 50-kDa regions are required for ATP-
induced dissociation of actomyosin.The switch II region is critical for formation
of the closed NBP actomyosin.ADP conformation
Our FRET results show that both switch II mutations disrupt
the formation of the closed NBP in the presence of ADP and
actin (K05A). However, in the absence of actin, the E442A
mutation behaves similarly to wild-type MV in its ability
to adopt a more closed NBP conformation at low tempera-
tures (22). Our results demonstrate that the formation or
stabilization of the closed NBP conformation in the pres-
ence of actin may require the salt bridge between switch I
and switch II. Alternatively, the E442A mutant may disrupt
other interactions in the active site required for NBP closure
in the actomyosin.ADP state, including Mg2þ coordination.
Rosenfeld et al. (25) proposed that after ATP hydrolysis and
actin-activated phosphate release, ADP release is governed
by an initial loss of Mg2þ coordination followed by NBP
opening (K5A) and ADP release from the AM.ADPW state
(K5B). A study by Nagy et al. (46) indicated a prominent
role for switch II in mediating the Mgþ2-dependent release
of ADP in the presence of actin. Mg2þ is chiefly coordinated
by S218 of switch I and T170 of the P loop, but Mg2þ coor-
dination via switch II may directly or indirectly play a role
in governing the closed-open transition of the NBP (K5A).
The PCA performed with the NBP subspace did indicate
that the mutants contain altered dynamics of the N-terminal
region of switch II and especially D437, which has been
implicated to coordinate Mg2þ through a water molecule
(51). We interpret our results in the context of Scheme 2,
where after phosphate release switch I and switch II
adopt a novel conformation, allowing a closed NBP and
actin-binding cleft (AM.ADPS). The transition into the
AM.ADPW state requires conformational changes in both
switch I and switch II, which is supported by our results
demonstrating a change in the mant-FlAsH FRET during
this transition (22) and the impact of switch II mutations
on this transition (Fig. 4 and Fig. S2). Overall, our results
suggest that the switch II region is involved in the formationof the closed NBP conformation in the presence of ADP,
which is a state that can simultaneously bind actin and
ADP with a high affinity.Implications for the role of switch II
in the mechanochemical cycle of myosins
Interestingly, both switch II mutants have a more significant
impact in the presence of actin, supporting the hypothesis
that switch II can adopt a novel conformation in the presence
of actin. There is certainly evidence for multiple con-
formations of switch I (44) and switch II (3,11), and there-
fore it is an oversimplification to suggest they exist in
either an open or a closed conformation. Our results obtained
in the presence of actin highlight a potential coupling
pathway that involves the actin-binding region, switch II,
and the lever arm. Studies have directly demonstrated a
role for switch II in transitioning the relay helix from a kinked
to a straight conformation, which is thought to drive the
formation of the prepower stroke conformation (49,51,52),
while the reverse process during the power stroke has yet
to be demonstrated. Our results suggest that the conforma-
tion of switch II is altered by interactions with the upper
and lower 50-kDa domain, and we can speculate that these
interactions may play a role in actin-activated phosphate
release and coupling actin binding with the force-generating
swing of the lever arm. Substantial evidence indicates that
the rate of ADP release is altered by the load or strain placed
on the lever arm (19–21); however, the structural mechanism
of load dependence remains elusive. Our results demon-
strating that switch II plays a role in the formation of the
closed NBP AM.ADPS state suggest that coupling between
the lever arm and switch II via the relay helix may be an
important communication pathway associated with strain-
dependent ADP release. Future studies will further define
the allosteric communication pathways in myosins and the
structurally related P-loop NTPases by using a combination
of intrinsic and extrinsic probes to characterize both global
and local conformational changes.SUPPORTING MATERIAL
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www.biophysj.org/biophysj/supplemental/S0006-3495(12)00470-5.
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